AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24135087 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycaemic index meal (GI 37)
Number of subjects: 10
Study 24135087 — intervention group
Group type: EXPERIMENTAL
Intervention: High glycaemic index meal (GI 73)
Number of subjects: 10
Study 24135087 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified, but implied as standardised premeal and fasting)
Number of subjects: 10
Study 21279703 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly low-dose gemcitabine (100 mg/m² over 30 min 1-2 h before radiotherapy)
Number of subjects: 216
Study 21279703 — intervention group
Group type: COMPARATOR
Intervention: Weekly low-dose paclitaxel (20 mg/m² over 60 min 4-6 h before radiotherapy)
Number of subjects: 216
Study 21279703 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly low-dose gemcitabine
Number of subjects: 216
Study 21279703 — intervention group
Group type: COMPARATOR
Intervention: Weekly low-dose paclitaxel
Number of subjects: 216
Study 19453519 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous chondrocyte implantation and combination products; specific dosage and duration not mentioned.
Number of subjects: 0
Study 19453519 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth factor research; specific details not mentioned.
Number of subjects: 0
Study 19453519 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellular and molecular studies using new technologies; specific details not mentioned.
Number of subjects: 0
Study 19453519 — intervention group
Group type: EXPERIMENTAL
Intervention: Careful selection of patient groups; specific details not mentioned.
Number of subjects: 0
Study 19453519 — intervention group
Group type: EXPERIMENTAL
Intervention: Study outcome parameters; specific details not mentioned.
Number of subjects: 0
Study 19453519 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced pain and improved function; specific details not mentioned.
Number of subjects: 0
Study 17549880 — intervention group
Group type: EXPERIMENTAL
Intervention: Training for fathers, details on dosage and duration not available
Number of subjects: 0
Study 17549880 — intervention group
Group type: COMPARATOR
Intervention: Absence of a father-figure
Number of subjects: 0
Study 17549880 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatherhood as a factor of male personality development
Number of subjects: 0
Study 15651990 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention programme
Number of subjects: 0
Study 15651990 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 0
Study 14592254 — intervention group
Group type: EXPERIMENTAL
Intervention: Pergolide
Number of subjects: 15
Study 10101624 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal anaesthesia with bupivacaine 0.25% 1 mL kg‐1 combined with general anaesthesia but without opioids
Number of subjects: 40
Study 10101624 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia including intravenous fentanyl
Number of subjects: 40
Study 8789469 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-coated circuits (group HC)
Number of subjects: 20
Study 8789469 — intervention group
Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 20
Study 2263886 — intervention group
Group type: EXPERIMENTAL
Intervention: K-pouch
Number of subjects: 55
Study 2263886 — intervention group
Group type: COMPARATOR
Intervention: J-pouch
Number of subjects: 55
Study 383195 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 0
Study 383195 — intervention group
Group type: COMPARATOR
Intervention: Diamorphine
Number of subjects: 0
Study 31754697 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation
Number of subjects: 110
Study 31754697 — intervention group
Group type: COMPARATOR
Intervention: Control group (no DHA supplementation)
Number of subjects: 110
Study 31152327 — intervention group
Group type: COMPARATOR
Intervention: Anastrozole (A)
Number of subjects: 870
Study 31152327 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant plus Anastrozole (A + F)
Number of subjects: 870
Study 27836979 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild ovarian stimulation strategy (low-dose gonadotropins 150 IU FSH, GnRH-antagonist)
Number of subjects: 394
Study 27836979 — intervention group
Group type: COMPARATOR
Intervention: Conventional ovarian stimulation strategy (high-dose gonadotropins 450 IU HMG, long mid-luteal GnRH-agonist)
Number of subjects: 394
Study 27836979 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild ovarian stimulation strategy
Number of subjects: 394
Study 26001819 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 1509
Study 26001819 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 1509
Study 26001819 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent
Number of subjects: 1509
Study 23041709 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic (training and curriculum only)
Number of subjects: 2841
Study 23041709 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic Plus (training and curriculum plus CATCH facilitator support)
Number of subjects: 2841
Study 23041709 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic Plus Social Marketing (all inputs plus social marketing component)
Number of subjects: 2841
Study 23041709 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 2841
Study 21345699 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% HES130/0.4 balanced (Volulyte)
Number of subjects: 81
Study 21345699 — intervention group
Group type: COMPARATOR
Intervention: 6% HES130/0.4 saline (Voluven)
Number of subjects: 81
Study 19732667 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-ligating bracket system (SmartClip, 3M Unitek)
Number of subjects: 60
Study 19732667 — intervention group
Group type: COMPARATOR
Intervention: Conventional preadjusted edgewise brackets (Victory, 3M Unitek)
Number of subjects: 60
Study 17215757 — intervention group
Group type: EXPERIMENTAL
Intervention: With Alexis retractor
Number of subjects: 221
Study 17215757 — intervention group
Group type: COMPARATOR
Intervention: Without Alexis retractor
Number of subjects: 221
Study 17215757 — intervention group
Group type: EXPERIMENTAL
Intervention: With Alexis retractor (colorectal surgery subgroup)
Number of subjects: 221
Study 15225887 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone (METH)
Number of subjects: 154
Study 15225887 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP)
Number of subjects: 154
Study 15225887 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone (METH) and Buprenorphine (BUP)
Number of subjects: 154
Study 11463927 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal douching (general)
Number of subjects: 543
Study 11463927 — intervention group
Group type: EXPERIMENTAL
Intervention: Douching with soap and water
Number of subjects: 543
Study 11463927 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of douching
Number of subjects: 543
Study 11463927 — intervention group
Group type: EXPERIMENTAL
Intervention: Douching
Number of subjects: 543
Study 9555597 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 2 mg twice daily
Number of subjects: 108
Study 9555597 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 108
Study 7990068 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological preparation
Number of subjects: 74
Study 7990068 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control procedure
Number of subjects: 74
Study 7990068 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 74
Study 2688602 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 25 mg
Number of subjects: 0
Study 2688602 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 790552 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (3.6 g daily)
Number of subjects: 12
Study 790552 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (200 mg daily)
Number of subjects: 12
Study 790552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31639265 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual information
Number of subjects: 300
Study 31639265 — intervention group
Group type: COMPARATOR
Intervention: Verbal information
Number of subjects: 300
Study 31639265 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 300
Study 28168769 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% TAC ointment (n = 11)
Number of subjects: 27
Study 28168769 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% TRI paste (n = 7)
Number of subjects: 27
Study 28168769 — intervention group
Group type: COMPARATOR
Intervention: Orabase® paste as PLA (n = 9)
Number of subjects: 27
Study 28168769 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between TAC and TRI
Number of subjects: 27
Study 25798680 — intervention group
Group type: EXPERIMENTAL
Intervention: Recipient pretransplant vaccination
Number of subjects: 122
Study 25798680 — intervention group
Group type: EXPERIMENTAL
Intervention: Donor pretransplant vaccination
Number of subjects: 122
Study 25798680 — intervention group
Group type: COMPARATOR
Intervention: No pretransplant vaccination
Number of subjects: 122
Study 22740153 — intervention group
Group type: EXPERIMENTAL
Intervention: RFVTR (bipolar radiofrequency volumetric tissue reduction)
Number of subjects: 22
Study 22740153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 21266004 — intervention group
Group type: EXPERIMENTAL
Intervention: Local and intraarticular analgesic injection (LIA) composed of 5 mg morphine, 30 mg bupivacaine (15 mg/1.5 mL), 1 mL betamethasone, and 0.5 mL epinephrine (1:1,000)
Number of subjects: 80
Study 21266004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 21266004 — intervention group
Group type: EXPERIMENTAL
Intervention: Local and intraarticular analgesic injection (LIA)
Number of subjects: 80
Study 19432231 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitaprost tablets
Number of subjects: 0
Study 16422733 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-cm thermoactive viscoelastic foam overlay with a water-filled warming mattress
Number of subjects: 175
Study 16422733 — intervention group
Group type: COMPARATOR
Intervention: Standard operating room table with a water-filled warming mattress (no pressure-reducing device)
Number of subjects: 175
Study 12921815 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrotherapy (n=15)
Number of subjects: 25
Study 12921815 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=10)
Number of subjects: 25
Study 10855070 — intervention group
Group type: EXPERIMENTAL
Intervention: Shouldice's repair (SR)
Number of subjects: 50
Study 10855070 — intervention group
Group type: COMPARATOR
Intervention: Moloney's darn repair (DR)
Number of subjects: 50
Study 9236504 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with nasal saline, sulfamethoxazole‐trimethoprim, antihistamine/decongestant, and five days of prednisone.
Number of subjects: 66
Study 9236504 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-treatment control).
Number of subjects: 66
Study 1548713 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharyngeotracheal lumen airway (PtL)
Number of subjects: 111
Study 1548713 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal tube (ET)
Number of subjects: 111
Study 2865614 — intervention group
Group type: EXPERIMENTAL
Intervention: Podophyllin application
Number of subjects: 60
Study 2865614 — intervention group
Group type: COMPARATOR
Intervention: Surgical excision
Number of subjects: 60
Study 28931460 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 weeks of computerized EF training (1h sessions 3 times per week and 40min daily home training)
Number of subjects: 25
Study 28931460 — intervention group
Group type: COMPARATOR
Intervention: Control training
Number of subjects: 25
Study 28931460 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 weeks of computerized EF training
Number of subjects: 25
Study 29881465 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefabricated foot orthoses
Number of subjects: 160
Study 29881465 — intervention group
Group type: COMPARATOR
Intervention: Customised foot orthoses
Number of subjects: 160
Study 26953193 — intervention group
Group type: EXPERIMENTAL
Intervention: Isavuconazole (prodrug isavuconazonium sulfate); administered intravenously and orally; specific dosage and duration not mentioned
Number of subjects: 0
Study 26953193 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects; control group
Number of subjects: 0
Study 24331121 — intervention group
Group type: EXPERIMENTAL
Intervention: L-PRF (N = 10)
Number of subjects: 20
Study 24331121 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 10)
Number of subjects: 20
Study 22183840 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic acyclovir therapy
Number of subjects: 0
Study 22183840 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20174641 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition of items as old in the presence of four confederates during the long version of the experiment.
Number of subjects: 0
Study 20174641 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition of items as old in the presence of four confederates during the short version of the experiment.
Number of subjects: 0
Study 20174641 — intervention group
Group type: EXPERIMENTAL
Intervention: Rejection of new items in the presence of four confederates during the short version of the experiment.
Number of subjects: 0
Study 17712576 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention (operated group)
Number of subjects: 25
Study 17712576 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment (non-operated group)
Number of subjects: 25
Study 17712576 — intervention group
Group type: COMPARATOR
Intervention: Cerebrospinal fluid NO(x) levels
Number of subjects: 25
Study 11343441 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP)
Number of subjects: 5888
Study 11343441 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP)
Number of subjects: 5888
Study 11343441 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse Pressure
Number of subjects: 5888
Study 11343441 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP) in treated hypertension
Number of subjects: 5888
Study 9757895 — intervention group
Group type: EXPERIMENTAL
Intervention: Double centrifugation
Number of subjects: 0
Study 9757895 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-tube swim-up
Number of subjects: 0
Study 9757895 — intervention group
Group type: EXPERIMENTAL
Intervention: Percoll density gradient
Number of subjects: 0
Study 8110548 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil at a plasma concentration of 0.145 ng ml‐1
Number of subjects: 76
Study 8110548 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil at a plasma concentration greater than 0.5 ng ml‐1
Number of subjects: 76
Study 8110548 — intervention group
Group type: COMPARATOR
Intervention: Plasma fentanyl concentration of 1.67 ng ml‐1
Number of subjects: 76
Study 3409138 — intervention group
Group type: EXPERIMENTAL
Intervention: Active drug
Number of subjects: 0
Study 3409138 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 0
Study 30900980 — intervention group
Group type: EXPERIMENTAL
Intervention: ethinyl estradiol 0.02 mg + levonorgestrel 0.10 mg + folic acid 0.4 mg
Number of subjects: 36
Study 30900980 — intervention group
Group type: COMPARATOR
Intervention: placebo coated tablet containing folic acid 0.4 mg only
Number of subjects: 36
Study 27774892 — intervention group
Group type: EXPERIMENTAL
Intervention: ATV+COBI
Number of subjects: 692
Study 27774892 — intervention group
Group type: COMPARATOR
Intervention: ATV+RTV
Number of subjects: 692
Study 26442402 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to recordings of their mothers' heartbeat and womb sounds via earphones during anaesthesia induction
Number of subjects: 40
Study 26442402 — intervention group
Group type: COMPARATOR
Intervention: Ambient noise via earphones
Number of subjects: 40
Study 23636760 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐mm lateral wedge condition
Number of subjects: 9
Study 23636760 — intervention group
Group type: COMPARATOR
Intervention: 6‐mm medial wedge condition
Number of subjects: 9
Study 21767403 — intervention group
Group type: EXPERIMENTAL
Intervention: IPTi with Sulfadoxine-Pyrimethamine (SP)
Number of subjects: 0
Study 21767403 — intervention group
Group type: COMPARATOR
Intervention: Control (non-IPTi zone)
Number of subjects: 0
Study 19567496 — intervention group
Group type: EXPERIMENTAL
Intervention: C-Flex (110 patients)
Number of subjects: 218
Study 19567496 — intervention group
Group type: COMPARATOR
Intervention: CPAP (108 patients)
Number of subjects: 218
Study 19567496 — intervention group
Group type: COMPARATOR
Intervention: CPAP therapy (< 4 h of use)
Number of subjects: 218
Study 19567496 — intervention group
Group type: EXPERIMENTAL
Intervention: C-Flex and CPAP
Number of subjects: 218
Study 16357312 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 8 mg daily
Number of subjects: 60
Study 16357312 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 15108041 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunochemotherapy group (MMC + 5‐FU + HCFU + OK‐432)
Number of subjects: 1429
Study 15108041 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy group (MMC + 5‐FU + HCFU)
Number of subjects: 1429
Study 15108041 — intervention group
Group type: COMPARATOR
Intervention: Control group (surgery alone)
Number of subjects: 1429
Study 15108041 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunochemotherapy group (MMC + 5‐FU + UFT + OK‐432)
Number of subjects: 1429
Study 15108041 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy group (MMC + 5‐FU + UFT)
Number of subjects: 1429
Study 11018229 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused psychoeducational treatment (FFT) - 21 sessions over 9 months
Number of subjects: 101
Study 11018229 — intervention group
Group type: COMPARATOR
Intervention: Comparison treatment (CM) - 2 family education sessions and follow-up crisis management over 9 months
Number of subjects: 101
Study 9066316 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (2 micrograms.kg.‐1. min‐1)
Number of subjects: 63
Study 9066316 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (1 mu.kg‐1.min‐1)
Number of subjects: 63
Study 9066316 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 63
Study 9066316 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 63
Study 8364194 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g/kg body weight i.v. IgG infusion
Number of subjects: 20
Study 8364194 — intervention group
Group type: COMPARATOR
Intervention: 2 g/kg body weight i.v. IgG infusion
Number of subjects: 20
Study 8364194 — intervention group
Group type: EXPERIMENTAL
Intervention: six 1 g/kg body weight i.v. IgG reinfusions
Number of subjects: 20
Study 31154891 — intervention group
Group type: EXPERIMENTAL
Intervention: Intoxicated condition (after smoking cannabis)
Number of subjects: 19
Study 31154891 — intervention group
Group type: COMPARATOR
Intervention: Non-intoxicated condition (free from cannabinoids for at least one week)
Number of subjects: 19
Study 28284202 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care model including a multidisciplinary team and continuous care coordination
Number of subjects: 5462
Study 28284202 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care model and provider‐level financial incentives
Number of subjects: 5462
Study 28284202 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5462
Study 26165216 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX) injections
Number of subjects: 16
Study 26165216 — intervention group
Group type: COMPARATOR
Intervention: Saline (NaCl) injections
Number of subjects: 16
Study 23458232 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-day parental education program (PEP)
Number of subjects: 59
Study 23458232 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment alone (Control)
Number of subjects: 59
Study 21807618 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized BH(4)
Number of subjects: 18
Study 21807618 — intervention group
Group type: EXPERIMENTAL
Intervention: Combo (arginase inhibited + BH(4)
Number of subjects: 18
Study 21807618 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin intervention (10 mg for 3 months)
Number of subjects: 18
Study 21807618 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized BH(4) after atorvastatin
Number of subjects: 18
Study 21807618 — intervention group
Group type: EXPERIMENTAL
Intervention: Combo after atorvastatin
Number of subjects: 18
Study 19896021 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-literacy medication education tool
Number of subjects: 166
Study 19896021 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard discharge instructions)
Number of subjects: 166
Study 17005501 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 60
Study 17005501 — intervention group
Group type: COMPARATOR
Intervention: Resistance exercise
Number of subjects: 60
Study 15175214 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lidocaine 2% gel
Number of subjects: 36
Study 15175214 — intervention group
Group type: COMPARATOR
Intervention: Intraurethral lubrication only (Control)
Number of subjects: 36
Study 11416115 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori positive (including CagA+ strains)
Number of subjects: 121
Study 11416115 — intervention group
Group type: EXPERIMENTAL
Intervention: CagA+ strains
Number of subjects: 121
Study 11416115 — intervention group
Group type: COMPARATOR
Intervention: Control (H. pylori negative)
Number of subjects: 121
Study 9296514 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinia melanoma oncolysate (VMO) vaccine
Number of subjects: 217
Study 9296514 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaccinia vaccine virus (V)
Number of subjects: 217
Study 8370370 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil, 20 mg b.d.
Number of subjects: 123
Study 8370370 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem, 60 mg t.d.
Number of subjects: 123